Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
9.90
-9.25 (-48.30%)
At close: Apr 28, 2026, 4:00 PM EDT
9.70
-0.20 (-2.00%)
After-hours: Apr 28, 2026, 4:29 PM EDT
Erasca Market Cap
Erasca has a market cap or net worth of $3.08 billion as of April 28, 2026. Its market cap has increased by 919.93% in one year.
Market Cap
3.08B
Enterprise Value
2.85B
1-Year Change
919.93%
Ranking
Category
Stock Price
$9.90
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has increased from $1.86B to $3.08B, an increase of 65.58%. That is a compound annual growth rate of 11.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 5.95B | 463.93% |
| Dec 31, 2025 | 1.06B | 48.72% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kymera Therapeutics | 6.93B |
| Arcellx | 6.75B |
| Protagonist Therapeutics | 6.38B |
| Belite Bio | 6.34B |
| Apogee Therapeutics | 6.32B |
| Terns Pharmaceuticals | 6.11B |
| Centessa Pharmaceuticals | 6.10B |
| Spyre Therapeutics | 6.01B |